1Kannel WB, Wolf PA, Benjamin EJ, et al. Prevalence, incidence,prognosis, and predisposing conditions for atrial fibrillation: population-based estimates [J]. Am J Cardiol, 1998, 82(8A):2N-9N.
2Gage BF, Fihn SD, White RH. Warfarin therapy for an octogenarian who has atrial fibrillation[J]. Ann Intern Med,2001, 134(6):465 -474.
3Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences ( Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology[J].Circulation ,2001, 104 (17): 2118 - 2150.
4Brannwald E. Cardiovascular medicine at the turn of the millennium:triumphs, concerns, and opportunities [J]. N Engl J Med, 1997,337:1360 - 1369.
5Kamath S, Blann AD, Chin BS, et al. A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation[J].J Am Coll Cardiol,2002, 40 (3):484-490.
6Li-Saw-HeeFL, BlannAD, LipGY. Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation[J]. Stroke, 2000, 31(4):828 -833.
7Vene N, Mavri A, Kosmelj K, et al. High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy[J]. Thromb Haemost, 2003, 90(6): 1163 -1172.
8Kahn SR, Solymoss S, Flegel KM. Nonvalvular atrialfibrillation: evidence for a prothrombotic state [J]. CMAJ, 1997, 157(6):673 -681.
9Roldan V, Marin F, Marco P, et al. Anticoagulant therapy modifies fibrinolytic dychronic atrial fibrillation[J]. Haemostasis, 2000, 30(4):219-224.
10Goldman ME, Pearce LA, Hart RG, et al. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: Ⅰ. Reduced flow velocity in the left atrial appendage ( The Stroke Prevention in Atrial Fibrillation [ SPAF-Ⅲ] study)[J]. J Am Soc Echocardiogr, 1999, 12(12): 1080 - 1087.
